Mebucaïne N, Lutschtabletten - 20 Swissmedic Key 66256001 Registration Holder Spirig HealthCare AG Name Mebucaïne N, Lutschtabletten Date of registration 26.10.2017 Introduction of Sequence 26.10.2017 ATC-Classification Cetylpyridinium (R02AA06) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) Show package size 20 Index Therapeuticus (Swissmedic) 12.03.30. Description Swissmedic categorie. D SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680662560017 Medication Code Synthetika Pharmacode Disponibility
Composition cetylpyridinii chloridum 2 mg, lidocaini hydrochloridum monohydricum 1 mg, menthae piperitae aetheroleum, levomentholum, acesulfamum kalicum, maydis amylum, acidum citricum monohydricum, macrogolum 6000, cellulosum microcristallinum, magnesii stearas, sorbitolum 1.107 g pro pastillo. Packungsbestandteile Galenic Form Lozenges Active Agent Dose Cetylpyridinium Chloride 2 mg Lidocaini Hydrochloridum Monohydricum 1 mg
Inactive agents Dose Acesulfamum Kalicum Citric Acid Monohydrate Cellulosum Microcristallinum Levomenthol Macrogol 6000 Magnesii Stearas Maydis Amylum Menthae Piperitae Aetheroleum Pro Pastillo Sorbitol 1.107 g
Source Data was imported : 07.02.2025
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
